Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment
Viruses · 2023
DOI: 10.3390/v15051165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Georgios Schinas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cytomegalovirus (CMV) reactivation has been linked to adverse clinical outcomes in critically ill patients, with emerging evidence suggesting a potential connection with severe COVID-19. Mechanisms driving this association may include primary lung injury, amplification of systemic inflammation, and secondary immunosuppression. Diagnostic challenges in detecting and assessing CMV reactivation necessitate a comprehensive approach to improve accuracy and inform treatment decisions. Currently, there is limited evidence on the efficacy and safety of CMV pharmacotherapy in critically ill COVID-19 patients. Although insights from non-COVID-19 critical illness studies suggest a potential role for antiviral treatment or prophylaxis, the risks and benefits must be carefully balanced in this vulnerable patient population. Understanding the pathophysiological role of CMV in the context of COVID-19 and exploring the advantages of antiviral treatment are crucial for optimizing care in critically ill patients. This review provides a comprehensive synthesis of available evidence, emphasizing the need for additional investigation to establish the role of CMV treatment or prophylaxis in the management of severe COVID-19 and to develop a framework for future research on this topic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, University of Patras, 26504 Patras, Greece.
- Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Patras, Greece.
- Department of Emergency Medicine, University Hospital ATTIKON, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- 3rd Department of Critical Care, EVGENIDIO Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
ORCID-Profile: Georgios Schinas, Maria Panagiota Almyroudi, Karolina Akinosoglou
Zitieren
APA
Schinas, G., Moustaka, V., Polyzou, E., Almyroudi, M. P., Dimopoulos, G., & Akinosoglou, K. (2023). Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment. Viruses. https://doi.org/10.3390/v15051165
Vancouver
Schinas G, Moustaka V, Polyzou E, Almyroudi MP, Dimopoulos G, Akinosoglou K. Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment. Viruses. 2023. doi:10.3390/v15051165
BibTeX
@article{Schinas2023,
author = {Schinas, Georgios and Moustaka, Vasiliki and Polyzou, Eleni and Almyroudi, Maria Panagiota and Dimopoulos, George and Akinosoglou, Karolina},
title = {Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15051165}
}
EUVIMED